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Objectives: Radiation emitted by the radionuclides in radioimmunotherapy (RIT) 
approaches induce direct killing of the targeted cells as well as indirect killing through 
the bystander effect. Our research group is dedicated to the development of α-RIT, i.e., 
RIT using α-particles especially for the treatment of multiple myeloma (MM). γ-irradiation 
and β-irradiation have been shown to trigger apoptosis in tumor cells. Cell death mode 
induced by 213Bi α-irradiation appears more controversial. We therefore decided to inves-
tigate the effects of 213Bi on MM cell radiobiology, notably cell death mechanisms as well 
as tumor cell immunogenicity after irradiation.
Methods: Murine 5T33 and human LP-1 MM cell lines were used to study the 
effects of such α-particles. We first examined the effects of 213Bi on proliferation rate, 
double-strand DNA breaks, cell cycle, and cell death. Then, we investigated autoph-
agy after 213Bi irradiation. Finally, a coculture of dendritic cells (DCs) with irradiated 
tumor cells or their culture media was performed to test whether it would induce DC 
activation.
results: We showed that 213Bi induces DNA double-strand breaks, cell cycle arrest, 
and autophagy in both cell lines, but we detected only slight levels of early apoptosis 
within the 120 h following irradiation in 5T33 and LP-1. Inhibition of autophagy prevented 
213Bi-induced inhibition of proliferation in LP-1 suggesting that this mechanism is involved 
in cell death after irradiation. We then assessed the immunogenicity of irradiated cells 
and found that irradiated LP-1 can activate DC through the secretion of soluble factor(s); 
however, no increase in membrane or extracellular expression of danger-associated 
molecular patterns was observed after irradiation.
conclusion: This study demonstrates that 213Bi induces mainly necrosis in MM cells, 
low levels of apoptosis, and autophagy that might be involved in tumor cell death.
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October 2015 | Volume 2 | Article 742
Gorin et al. Alpha particles induce autophagy
Frontiers in Medicine | www.frontiersin.org
inTrODUcTiOn
Ionizing radiation (IR) is widely used in the treatment of cancer. 
External beam radiation therapy (EBRT) using X- or γ-rays is a 
primary treatment for a wide range of localized cancer, brachy-
therapy is commonly used as an effective treatment for cervical, 
prostate, breast, and skin cancer, and radioimmunotherapy 
(RIT) using β-emitters has proved its efficacy for the treatment of 
refractory non-Hodgkin lymphoma (1, 2).
New trials are now assessing the efficacy of α-particle emitters 
in non-targeted or targeted therapies against hematological or 
solid cancers (3). Indeed, the physical and biological character-
istics of those radioisotopes make them attractive candidates for 
the treatment of disseminated or residual cancers. α-particles 
exhibit a high linear energy transfer (LET) (~100 keV/μm) with 
a short range of 50–90 μm into the tissues combined with a high 
energy of 5–9 MeV. In addition, energy deposition along their 
path follows a Bragg peak, resulting in an increased LET at the 
end of the track and therefore an increased cytotoxicity. Like 
other high LET particles, α-emitters induce complex clusters 
of DNA damages including DNA double-strand breaks (DSBs) 
which lead to a cell cycle arrest that is more marked than with 
γ-rays (4). Cell nucleus traversal with one to three α-particles is 
sufficient to cause tumor cell death when 1000–5000 β-emitters 
would be required (5). Furthermore, radiobiological effects 
associated with α-radionuclides are largely independent of 
dose rate, oxygenation, and cell proliferation (6). A few studies 
have investigated the cell death mechanisms in vitro and ex vivo 
after α-irradiation and led to contrasting results. Some groups 
showed that cells undergo apoptosis following exposure to 213Bi 
(7–9) while others observed cell death independent of apoptosis 
(10–12), therefore reinforcing the need for further investigation 
of such mechanisms.
Diverse α-emitters have been used in the clinic so far, 
displaying short half-lives, like 213Bi, 211At, and 212Pb as well as 
long-lived like 223Ra and 225Ac (3). Our group has done several 
in  vitro and preclinical studies on multiple myeloma (MM) 
(12–16) using 213Bi produced by 225Ac/213Bi radionuclide genera-
tors. Therefore, we thought to further investigate the impact of 
this α-emitter on the radiobiology of MM cells, especially cell 
death mechanisms.
Moreover, experiments using EBRT have shown that in addi-
tion to direct tumor cell killing, IR can generate specific immune 
responses directed against tumor cells. Besides creating a local 
inflammatory context, it has been demonstrated that irradiation 
can induce immunogenic cell death (ICD) of cancer cells along 
with the release of danger-associated molecular patterns 
(DAMPs) (17, 18). Inflammation, ICD, and DAMPs promote the 
recruitment of immune cells to the tumor site, such as dendritic 
cells (DCs), which can internalize dying tumor cells. Then cross-
presentation of tumor antigens by activated DCs primes antitu-
mor T-cell response (19). Recently, we and others have shown that 
α-particle emitters 213Bi or 224Ra can induce similar ICD of tumor 
cells (20–22) in combination with Hsp70 and HMGB-1 release, 
leading to efficient T-cell-dependent antitumor response (20, 21).
The aim of this study was to investigate the radiobiological 
effects, in particular cell death mechanisms, of 213Bi on MM 
cells and to assess if irradiation of these tumor cells can lead 
to immune cell activation. Murine 5T33 and human LP-1 MM 
cell lines were used; we showed that 213Bi induces inhibition of 
proliferation, DSBs, cell cycle arrest, and autophagy in both cell 
lines. Inhibition of autophagy prevented 213Bi-induced inhibi-
tion of proliferation in LP-1, suggesting that autophagy is one 
of the tumor cell death mechanisms after α-irradiation. We then 
evaluated the immunogenicity of irradiated cells and found that 
irradiated LP-1 can activate DCs through the secretion of soluble 
factor(s).
MaTerials anD MeThODs
cell culture, 213Bi-irradiation, and 
Pharmacological Treatment
5T33 (provided by Dr. Radl, TNO Institute, Leiden, Netherlands) 
and LP-1 cells (DSMZ: ACC 41) were maintained in RPMI 1640 
(Gibco) supplemented with 10% FCS, 2 mM glutamine (Gibco), 
100  U/mL penicillin, and 100 μg/mL streptomycin (Gibco) at 
37°C and 5% CO2.
At least 2  h prior to irradiation, the cells were plated at 
8 × 105 cells/mL in fresh culture medium. A solution containing 
213Bi diluted in culture medium was then added to the cells. Thus, 
a final concentration of 4 × 105 cells/mL was obtained in the pres-
ence of the desired activity of 213Bi.
For autophagy inhibition, cells were treated with 1.25  mM 
3-methyladenine (3-MA) (Sigma).
Preparation of 213Bi-Bsa
Cyclohexyl diethylene triamine penta-acetic acid (CHX-A″-
DTPA; Macrocyclics) was conjugated to BSA (Sigma) and 
controlled by indium labeling. For labeling with 213Bi, conjugated 
BSA was incubated with 213Bi eluted from a 225Ac/213Bi generator 
(Institute for Transuranium Elements, Karlsruhe, Germany) 
for 10 min at 37°C in 0.4 M ammonium acetate (pH, 5.3). The 
resulting 213Bi–BSA conjugate was purified from unbound 213Bi 
by size exclusion chromatography using a PD-10 column (GE 
Healthcare).
3h-Thymidine incorporation assay
Approximately 16  h after 213Bi-irradiation, cells were plated 
in quadruplicates at 4 × 105 cells/mL in 100 μL in 96-well flat-
bottom microtiter plates and incubated at 37°C. Forty-two hours 
after irradiation, 10 μL of 3H-thymidine (925  kBq/mL; Perkin 
Elmer) was added to each well and incubated at 37°C. Six hours 
later (i.e., 48 h after irradiation), cells were harvested (Harvester 
96 – Tomtec) on glass fiber Filtermat A (Perkin Elmer). Radioactive 
emission was amplified with Betaplate Scint (Perkin Elmer) and 
read using 1450 Microbeta Plus counter (Wallac). Results are 
expressed as quadruplicate mean ± SD.
colony-Forming assay
Sixteen hours after irradiation, cells were plated in 96-well 
U-bottom microtiter plates at densities of 30, 10, 1, and 0.3 cells 
per well and cultured 2–3 weeks at 37°C, 5% CO2. Growth fre-
quency was then calculated using Poisson distribution.
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γh2aX staining
5T33 and LP-1 cells were fixed with 2% PFA (EMS, Washington, 
PA, USA) and permeabilized with methanol in PBS–0.5% BSA. 
γH2AX staining was performed with PE-γH2AX antibody (BD 
Pharmingen) for 1  h at 4°C. After two washes with PBS–0.5% 
BSA and once with PBS, analysis of at least 10,000 events was 
performed using a BD FACScalibur flow cytometer and FlowJo 
software.
cell cycle analysis
Cells were harvested, centrifuged, and resuspended in 200 μL 
PBS. LP-1 and 5T33 were fixed by adding 1 mL of cold ethanol or 
methanol, respectively, for at least 10 min at 4°C. Cells were then 
stained with propidium iodide as described previously (13) and 
at least 10,000 events were analyzed using a BD FACScalibur flow 
cytometer and FlowJo software.
annexin V and 7-aaD staining
Staining was performed according to manufacturer’s instructions 
(BD Annexin V-PE Apoptosis detection kit). Briefly, 105 cells 
were stained with 5 μL Annexin V-PE and/or 7-AAD for 15 min 
at room temperature in the dark. At least 10,000 events were ana-
lyzed using BD FACScalibur flow cytometer and FlowJo software.
Western Blotting
Cells were lysed in 1% Triton X-100 lysis buffer containing 
protease inhibitors (5 μg/mL aprotinin, 5 μg/mL leupeptin, and 
4 mM Pefablock®) for 15 min on ice. Cell debris were pelleted at 
11,000 × g for 20 min at 4°C, and protein concentrations were 
determined by BCA reagent (Interchim). Proteins were separated 
by SDS-PAGE in a 15% acrylamide gel and transferred onto 
PVDF membranes. Blots were incubated 1 h in blocking buffer 
(TBS, 0.1% Tween 20, and 5% milk) before incubation for 2 h 
with primary antibodies either rabbit anti-LC3B antibody (1 μg/
mL; Sigma) that recognizes both LC3B-I and LC3B-II forms or 
goat anti-actin (C-11, 50  ng/mL; Santa Cruz, CA, USA). Blots 
were then incubated 1 h with the appropriate HRP-conjugated 
secondary antibody and processed to detect electrochemilu-
minescence (Roche). The signal was acquired with the Fusion 
FX7 camera and its intensity determined using Bio-1D software 
(Vilber Lourmat).
Transmission electron Microscopy
Non-irradiated and 213Bi-irradiated 5T33 and LP-1 cells were 
fixed in cacodylate buffered 4% glutaraldehyde for 15  min at 
4°C, washed, and post-fixed in cacodylate buffered 2% osmium 
tetroxide for 20 min at 4°C. Samples were dehydrated in succes-
sive dilutions of ethanol and embedded overnight in Epon at 37°C 
and for two other days at 55°C. Sections (80 nm thick) were cut 
with an Ultracut E ultramicrotome (Reichert-Jung), mounted on 
copper grids, stained with uranyl acetate, and observed on a JEOL 
1010 TEM.
Dcs Production
Human DCs were obtained by differentiation of human mono-
cytes. Monocytes were purified from PBMCs by counterflow cen-
trifugal elutriation and cultured 5 days in RPMI supplemented 
with 2% human albumin, 2 mM glutamine, 100 U/mL penicillin, 
100 μg/mL streptomycin, GM-CSF 1000 IU/mL (CellGro), and 
IL-4 200 IU/mL (BruCells). Mouse DCs were obtained by differ-
entiation of bone marrow from C57Bl/6 thigh bone as described 
previously (20).
coculture assays
For DC coculture assay with tumor cells, five million 
213Bi-treated tumor cells (LP-1 or 5T33) or non-irradiated 
tumor cells were centrifuged 48 h after irradiation. Tumor cell 
pellets were resuspended in 1 mL fresh medium and added to 
one million DCs (human or mouse) in a total volume of 2 mL 
and plated in six-well dishes. Twenty-four hours after coculture 
at 37°C, DC maturation was analyzed by immunofluorescence 
phenotyping.
For DC coculture assay with tumor cell supernatant, 48  h 
after irradiation, 1  mL of tumor cell supernatant, obtained 
after centrifugation of five million irradiated or non-irradiated 
tumor cells (LP-1 or 5T33), was added to one million DCs 
(human or mouse) in a total volume of 2  mL and plated in 
12-well plates.
immunofluorescence analysis
Cells were washed once in 0.1% BSA–PBS and then stained for 
1 h at 4°C with primary antibody. When secondary antibody was 
needed, cells were washed three times in 0.1% BSA–PBS before 
incubation with secondary antibody. After staining, cells were 
washed twice in 0.1% BSA–PBS and once in PBS before acquisition 
in flow cytometer. The following antibodies and their respective 
control isotypes were used in this study: PE anti-human CD80 
(L307.4; BD), APC anti-human CD83 (HB15e; BD), APC anti-
human CD86 (2331 FUN-1; BD), and PE anti-HLA-DR (G46.6; 
BD). All immunofluorescence analyses were performed using 
a FACScalibur flow cytometer (BD Pharmingen) and analyzed 
with FlowJo software.
resUlTs
213Bi irradiation hampers cell Proliferation
5T33 cells and LP-1 cells were irradiated with increasing activi-
ties of 213Bi and their proliferation rate was assessed 48  h later 
by 3H-thymidine incorporation assay. Results show a dose-
dependent inhibition of 3H-thymidine incorporation attesting 
of a diminution of DNA synthesis and as a result a diminution 
of their proliferation ability (Figure 1). 213Bi activities sufficient 
to cause at least 80% inhibition of proliferation for each cell line 
were then used for the rest of the study, respectively, 370 kBq/
mL for 5T33 and 425 kBq/mL for LP-1. Such activities ensure a 
strong biological effect but remain low enough that the cells are 
not sterilized by irradiation.
inhibition of Proliferation is correlated 
with Tumor cell Death
In order to determine to what extend the inhibition of prolifera-
tion had an impact on tumor cell survival, we performed colony-
forming assays. This approach consists in seeding irradiated and 
non-irradiated cells in clonal conditions to measure the impact 
TaBle 1 | colony-forming assay of 5T33 and lP-1 cells after 213Bi 
irradiation.
cells condition growth efficiency (%) survival (%) Death (%)
5T33 Control 22.4 ± 6.0 100 0
370 kBq/mL 5.8 ± 1.8 26.5 ± 4.6 73.5 ± 4.6
LP-1 Control 40.2 ± 31.6 100 0
425 kBq/mL 6.4 ± 6.7 11.2 ± 7.1 88.8 ± 7.1
Colony-forming assays were performed 16 h after irradiation with non-irradiated 
or 213Bi-irradiated 5T33 (370 kBq/mL) and LP-1 (425 kBq/mL) cells to determine 
growth using Poisson distribution. Data represent mean ± SD of three independent 
experiments.
FigUre 2 | clonogenic death of 5T33 and lP-1 cells after 213Bi 
irradiation. Cell death of 213Bi-irradiated 5T33 (370 kBq/mL) and LP-1 
(425 kBq/mL) was calculated as defined in Table 1. Data represent 
mean ± SD of three independent experiments.
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of 213Bi irradiation on cell growth efficiency. We observed that 
clonogenic cell death after irradiation reached 73.5 ±  4.6% for 
5T33 cells treated at 370 kBq/mL and 88.8 ± 7% for LP-1 treated 
at 425 kBq/mL (Figure 2; Table 1). This confirmed that blockade 
of 5T33 and LP-1 cell proliferation is indeed correlated to the 
same extent to tumor cell death induced on the long term after 
213Bi treatment.
FigUre 1 | inhibition of cell proliferation by 213Bi irradiation. Proliferation of irradiated 5T33 (a) and LP-1 (B) cells assessed 48 h after irradiation by 
incorporation of 3H-thymidine. Data are expressed as quadruplicate mean ± SD and are representative of two independent experiments.
213Bi induces Dna DsBs in MM cells
Induction of DSBs in 5T33 and LP-1 cells was investigated after 
213Bi irradiation at 370  kBq/mL or 425  kBq/mL, respectively 
(Figure  3). Irradiation appeared homogenous since for both 
cell lines, the entire cell population exhibited γH2AX staining 
(Figure 3). For both cell lines also, DSBs were detectable already 
15  min after treatment and their amount increased following 
the same kinetic over time to reach a maximum at 2  h. Then, 
phosphorylation of H2AX histone decreased, as observed 3  h 
after irradiation.
213Bi Blocks cell cycle
Cell cycle arrest can arise from DNA damages; therefore, the 
effect of 213Bi on 5T33 and LP-1 cell cycle at different time 
points following irradiation was then investigated (Figure  4). 
Accumulation in the G2/M phase occurred quite rapidly after 
irradiation in both cell lines. In 5T33 cells (Figure 4A), cell cycle 
blockade was seen as soon as 6 h after irradiation with 370 kBq/
mL of 213Bi and reached a maximum at 24 h with around 45% 
of the cells in the G2 phase. In LP-1 cells (Figure 4B), cell cycle 
blockade was slower, being noticeable 24 h after treatment with 
425 kBq/mL and reaching a maximum at 36 h with almost 63% 
of the cells blocked in the G2 phase. These results demonstrate 
that α-particles cause a blockade at the G2/M checkpoint with a 
kinetic that varies depending on the cell line.
213Bi induces necrosis in MM cells
Since 5T33 and LP-1 cells experience serious DSBs, are blocked 
in G2 phase, and stop proliferating after 213Bi irradiation, experi-
ments were conducted to determine the mechanisms that would 
eventually lead to cell death. Annexin V/7AAD staining was 
performed on the two MM cell lines at different time points after 
irradiation to investigate early apoptosis [Annexin V (+) cells] 
as well as late apoptosis and necrosis [Annexin V (+) 7AAD 
(+) cells] (Figure 5). Non-irradiated MM cells were studied in 
parallel. Early apoptosis was barely detectable in any of the cell 
lines and was not observed immediately after irradiation but to a 
small extent at later time point, after 36 h for 5T33 and 96 h for 
FigUre 4 | accumulation in g2 phase of 213Bi-irradiated 5T33 and lP-1 cells. 5T33 (a) and LP-1 (B) cells were irradiated at 370 and 425 kBq/mL, 
respectively. Then cell cycle analysis was performed at different time points after 213Bi irradiation of the cells (black bars) and compared to control non-irradiated cells 
(white bars). Data represent mean ± SD of two independent experiments.
FigUre 3 | DsBs are induced shortly after irradiation with 213Bi. 5T33 (a) and LP-1 (B) cells were irradiated at 370 and 425 kBq/mL, respectively. DSBs were 
analyzed at different time points after irradiation by flow cytometry using an anti-γH2AX mAb. Flow cytometry histograms illustrate homogeneous γH2AX staining for 
both cell lines: 0 min (light gray), 30 min (dark gray), and 120 min (black). Bar graphs represent median ± SD of two independent experiments.
October 2015 | Volume 2 | Article 745
Gorin et al. Alpha particles induce autophagy
Frontiers in Medicine | www.frontiersin.org
LP-1. These data suggest that cell death occurs mainly through 
necrosis. This was confirmed by active caspase-3 detection and 
DNA fragmentation analysis that also showed small levels of early 
apoptosis (data not shown). In 5T33 cells, necrosis appeared at 
36 h and reached a maximum at 96 h after irradiation at 370 kBq/
mL of 213Bi. In LP-1, necrosis seems to arise later and is strikingly 
increased at 96 h after irradiation at 425 kBq/mL. Non-irradiated 
5T33 control cells kept dividing actively over the time of the 
experiment and despite splitting exhibited important cell death 
as observed after 96 h of culture.
213Bi induces autophagy in MM cells
Autophagy can be induced in cells as a response to a variety of 
stress factors, including IR-induced oxidative stress, and is char-
acterized by an increased number of autophagosomes that exhibit 
a lipid bilayer membrane. At the molecular level, when autophagy 
is activated, the LC3-B protein is converted from the cytosolic 
LC3B-I form to the LC3B-II form recruited on the autophagosome 
membrane. Common methods to assess autophagy are Western 
blot of the LC3-B protein, TEM, and use of autophagy inhibitors.
Western blot assays on irradiated and non-irradiated MM 
cell lysates were analyzed by standardization of LC3B-II form 
to actin as mentioned by Mizushima and Yoshimori (23) and 
showed a strong induction of LC3B-I form conversion to the 
LC3B-II form after 213Bi irradiation (Figure 6). Accumulation of 
the LC3B-II form of the LC3B protein was observed in 5T33 cells 
at 24 h, further increased at 36 h, and remained stable until 72 h 
after irradiation at 370 kBq/mL. In LP-1 cells, after a transient 
and early accumulation at 16 h, LC3B-II form decreased before 
raising again at 48 h and remained stable at 96 h after treatment 
with 425 kBq/mL of 213Bi. For both cell lines, non-irradiated cells 
did not exhibit major changes in LC3B-II form accumulation 
over the time of experiments (Figure 6). Moreover, the presence 
of autophagosomes in 213Bi-treated 5T33 and LP-1 cells was 
confirmed by TEM analysis (Figure 7). Altogether, these results 
demonstrate that α-particles induce autophagy in MM cells.
Autophagy has been described both as a cell survival and cell 
death mechanism depending on the stimuli, context, and/or cell 
lines studied. To assess the role of autophagy in our cell lines after 
irradiation with 213Bi, both proliferation and colony-forming assays 
FigUre 5 | apoptosis and necrosis in MM cells after 213Bi irradiation. Early apoptosis (white bars) and late apoptosis/necrosis (gray bars) were 
assessed at different time points after irradiation of 5T33 cells (a) at 370 kBq/mL and LP-1 cells (B) at 425 kBq/mL. Data are representative of two independent 
experiments.
FigUre 6 | 213Bi irradiation induces autophagy in 5T33 and lP-1 cells. To analyze autophagy, Western blot analysis of LC3B I conversion to the LC3B II form 
was performed at different time points after irradiation in 5T33 cells (a) at 370 kBq/mL and LP-1 cells (B) at 425 kBq/mL. Densitometry analysis of the blots was 
performed to determine the LC3B II to actin ratios in control non-irradiated (white bars) and irradiated (black bars) 5T33 (c) and LP-1 (D) cells. Data are 
representative of three independent experiments.
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FigUre 7 | electron microscopy of 213Bi-treated cells. Analysis was performed on 5T33 cells: untreated (a) or 48 h after irradiation with 370 kBq/mL 213Bi (B) 
and on LP-1 cells: untreated (c) or 72 h after irradiation with 425 kBq/mL 213Bi (D). Autophagic vacuoles presenting lipid bilayer membrane are indicated by arrows.
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were conducted in the presence of an autophagy  inhibitor  –  3- 
methyladenine (3-MA) – which inhibits more specifically class III 
phosphoinositide 3-kinase activity known to be essential for 
autophagy induction. In 5T33, at 1.25 mM of 3-MA, the prolif-
eration rate after 213Bi treatment with or without inhibition of 
autophagy was quite similar (data not shown). However, for LP-1 
cells, when autophagy was blocked by 3-MA, the proliferation rate 
after irradiation was affected. As shown in Figure 8A, the amount 
of 3-MA used in that experiment had no major effect on prolifera-
tion of non-irradiated LP-1 cells. As shown previously, treatment of 
LP-1 cells at 425 kBq/mL with 213Bi induced around 90% decrease 
in proliferation rate. Then, when LP-1 cells were irradiated with 
213Bi in the presence of 3-MA, the cells appeared protected from 
irradiation and kept proliferating at least for 72 h. These results 
raise the hypothesis that autophagy is involved, at least in part, as 
a cell death mechanism after treatment with 213Bi. Nevertheless, 
when clonogenic colony assays were performed on 213Bi-irradiated 
LP-1 in the presence of 3-MA, cell death occurred to the same 
extent with or without autophagic inhibition (Figure 8B).
213Bi-Treated Tumor cells activate 
Dendritic cells
Besides its direct killing of tumor cells, IR has been shown to 
induce indirect killing via the immune system. To assess the 
immunogenicity of alpha-irradiated tumor cells, 213Bi-treated 
LP-1 (425 kBq/mL) or their culture media have been cultured with 
human DCs. After 1 day of coculture, the DC expression of activa-
tion markers (CD80, CD83, CD86, and HLA-DR) was determined 
by flow cytometry. The culture media of irradiated LP-1 yielded a 
strong activation of DCs (Figure 9). However, such activation was 
not observed when DCs were cocultured directly with the irradi-
ated cells alone (without their culture media) (Figure 9). Coculture 
with irradiated tumor cells plus their culture media did not result 
in further DC activation (data not shown). These data suggest that 
the factor(s) capable of activating DCs are secreted in the culture 
media after irradiation with 213Bi. Experiments performed with 
irradiated 5T33 cells and irradiated 5T33 cell supernatants showed 
quite similar results on murine DC activation.
To identify the potential factor(s), dosage of common DAMPs 
was performed on culture media of irradiated 5T33 and LP-1 at 
370 kBq/mL or 425 kBq/mL, respectively. No difference in release 
of HMGB1, Hsp70, or TNFα was observed after irradiation with 
213Bi (data not shown). The membrane expression of Hsp70, 
Hsp90, and calreticulin was also tested by flow cytometry; again, 
no difference was seen after α-irradiation (data not shown).
DiscUssiOn
In this study, we showed that 213Bi irradiation of MM cells induced 
DSBs followed by a cell cycle arrest in G2/M phase and an increased 
FigUre 8 | inhibition of autophagy restores proliferation of lP-1 cells but do not impact clonogenic cell death. (a) Proliferation of irradiated or control 
LP-1 cells with or without autophagic inhibitor was assessed 72 h after irradiation by incorporation of 3H-thymidine. (B) Clonogenic cell death of untreated LP-1 or 
after 213Bi irradiation with or without autophagic inhibitor. Data represent mean ± SEM of two independent experiments.
FigUre 9 | effect of 213Bi irradiation on immune cells. DC cell activation markers were analyzed 24 h after coculture with 213Bi-treated (black bars) LP-1 cells or 
LP-1 supernatants as well as untreated (white bars) LP-1 cells or LP-1 supernatants. Control DCs (dashed bars) cocultured alone were used as negative control (−), 
whereas DCs cocultured with LPS and TNFα were used as positive control (+). Data represent means of ratio of fluorescence intensity ± SEM of two independent 
experiments.
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amount of LC3B-II protein, indicating a raise in autophagy. 
Mechanisms leading to the death of irradiated cells seem to impli-
cate apoptosis, necrosis, and could also involve autophagy.
We used 213Bi-BSA, a non-specific vector in order to perform 
a homogeneous irradiation of the cells. Irradiation was indeed 
homogenous as demonstrated by the γH2AX flow cytometry 
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histograms, since 100% of cells exhibited DSBs with a maximum 
reached around 2  h after α-irradiation (Figure  3). Following 
induction of DSBs by 213Bi treatment, we observed a cell cycle 
blockade in the MM cells. IR is known to induce cell cycle arrest 
in G1 and G2 phase (24). However, cell cycle blockade in G1 is 
controlled by p53 and is therefore scarce in tumor cells. It has 
been shown that α-emitters could also induce a G1 arrest in cells 
that present a functional p53 (25, 26). The fact that neither LP-1 
nor 5T33 cells exhibit such blockade in G1 phase indicates that 
p53 is deficient in these cell lines. TP53 gene is actually mutated 
in LP-1 cells and is also hypermethylated compared to normal 
plasma cells (27). On the other hand, to our knowledge, no study 
has shown so far that p53 could be mutated or inactivated in the 
5T33 cells. Cell cycle arrest in G2/M phase is common in tumor 
cell lines and has been shown previously by our team and by oth-
ers on MM cells (9, 13) and on different types of cancer cell lines 
(4, 11). This G2/M arrest sensitizes the cells to a second irradia-
tion cycle. Even though they are less dependent than X-rays or 
γ-radiation, α-particle emitters are not completely insensitive 
to cell cycle distribution. Indeed, it has been demonstrated that 
α-irradiation of tumor cells was potentiated when cells were pre-
treated with chemotherapies that lead to a blockade in G2 phase 
(12, 28). These data suggest that combining such chemotherapies 
with α-RIT or repeated injection of α-RIT could enhance RIT 
treatment.
When we studied the cell death mechanisms resulting from 
213Bi irradiation, regardless of the detection method used, we 
observed only low levels of apoptosis, around 9% and 5% in 5T33 
and LP-1, respectively (Figure 5). p53 status in LP-1 and 5T33 
cell lines cannot be accounted for this result since both cell lines 
exhibited very high apoptosis during the same time frame when 
subjected to UV-B radiation (data not shown). A few studies have 
shown that tumor cells undergo apoptosis following 213Bi irra-
diation (7–9). These studies used different irradiation protocols, 
diverse methods to assess cell death, and various tumor cells, 
which might explain the discrepancy in the results. In particular, 
Teiluf et  al. (9) assessed apoptosis in human MM cells treated 
in  vitro with 213Bi-anti-CD38 mAb using Western blot analysis 
which makes difficult to estimate the percent of cells actually 
undergoing apoptosis. They observed caspase-3 activation and 
PARP cleavage 48–96 h after irradiation, which correlates with 
the time frame where we detected some apoptosis in 5T33 and 
LP-1 cells (Figure 5). Based on their results, we could hypothesize 
that those cells despite irradiation bypass the G2/M checkpoint 
to enter mitosis before undergoing apoptosis. This will have to be 
further studied.
Ionizing radiation induces different cell death mechanisms, 
including apoptosis, necrosis, necroptosis, mitotic catastrophe, 
senescence, and autophagic cell death (29–31). We followed 
cell death over 5  days after 213Bi treatment and we observed in 
between 55 and 95% mortality (Figure 5) while on the long term, 
clonogenic cell death reached 73.5–88.8% depending on the MM 
cell line (Table 1). Therefore, other cell death mechanisms might 
be involved later after irradiation, such as mitotic catastrophe 
that can occur after several cell divisions or cell senescence that 
would prevent colony formation. Alternatively, preliminary data 
in our group showed that expression of DRAM, a gene implicated 
in autophagy, was increased in T cells after irradiation with 211At 
and 213Bi (unpublished data). Therefore, we performed Western 
blot analyses of LC3B-II form, which is correlated with the pres-
ence of autophagosomes at different time points after irradiation 
with 213Bi. Our results show an increase of LC3B-II form after 
irradiation, and the presence of autophagosomes characterized 
by a lipidic bilayer membrane was confirmed through TEM. 
Altogether, these data suggest that α-emitters induce autophagy 
in MM cells. EBRT is known to induce autophagy (32), and few 
studies have shown that irradiation with high LET neutrons can 
also induce such mechanism (33, 34), but to our knowledge, no 
study so far had investigated the impact of α-particle emitters on 
autophagy.
The implication of autophagy in cell death has been ques-
tioned, being considered either as a programmed cell death 
mechanism (35, 36) or as a stress response mechanism which 
can eventually lead to cell death (37, 38). In our study, we 
observed that the use of autophagy inhibitor 3-MA resulted in 
protecting LP-1 against 213Bi-induced proliferation inhibition, 
suggesting that autophagy is involved in tumor sensitization 
to irradiation and cell death induction. Moreover, it has been 
already shown that excess autophagy could lead to MM cell 
death (39, 40). We also observed that when clonogenic colony 
assays were performed on 213Bi-irradiated LP-1 in the presence 
of 3-MA, cell death occurred to the same extent than without 
autophagic inhibition. This suggests that autophagy is involved 
in cell death after 213Bi irradiation, but when this mechanism is 
blocked, other cell death pathways are activated, for example, 
necrosis. However, to reinforce our data, we will have to further 
depict the exact mechanism of autophagy after 213Bi irradia-
tion, by confirming that 3-MA indeed acts on the amount of 
autophagosomes, by using other inhibitors like bafilomycin A1 
that inhibits the final phase of autophagy, the autophagosome 
degradation, or siRNA directed against protein involved in the 
autophagic process, and by studying more MM cell lines. It 
would also be interesting to investigate how cell death occurs 
when autophagy is inhibited with 3-MA. In this study, we did 
not observe any effect of 3-MA on the 5T33 cells after irradia-
tion. We used nevertheless the same inhibitor concentration in 
both MM cell lines (1.25 nM) even though they do not have the 
same proliferation rate. Indeed 5T33 cells cycle faster than LP-1 
cells with a doubling time around 14 versus 28 h, respectively. 
This cell cycle difference between the two cell lines was also 
noticeable in proliferation assays where mean 3H-thymidine 
incorporation was around 90,000  cpm for 5T33 at 0  kBq/mL 
versus around 54,000 cpm for LP-1 (Figure 1) as well as in cell 
cycle assays where G2/M arrest occurred already at 6  h after 
irradiation in 5T33 and at 24 h in LP-1 (Figure 4). Therefore, it 
would be important to repeat the experiments with increasing 
amounts of 3-MA to ensure that we use the optimal concentra-
tion in 5T33 cells.
The role of autophagy in cancer has also been a subject of 
debate. Some studies have shown that autophagy contributes 
to tumor cell radioresistance (41, 42) while others have dem-
onstrated that autophagy participates in tumor cell radiosen-
sitization (43, 44). However, a recent study has shown that if 
autophagy inhibition radiosensitizes tumor cells in vitro, it does 
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reduce in  vivo radioresponse highlighting the importance of 
the autophagic process in immunogenic signaling, especially 
through the release of ATP (45). Activation of autophagy is 
mandatory for ATP secretion in the extracellular medium (46) 
and leads to ICD (47). Extracellular ATP is a very potent che-
moattractant for immune cells to ICD sites (48) and promotes 
DCs differentiation (49), inflammasome activation, and further 
proinflammatory IL-1β cytokine secretion (50). In this study, we 
observed that 213Bi-treated MM cells, especially LP-1 cell line, 
released a soluble factor capable of activating DCs, suggesting 
that the tumor cells underwent ICD after α-irradiation. We 
recently demonstrated that 213Bi was indeed able of inducing 
ICD in MC-38 cells resulting in Hsp70 and HMGB1 secretion 
in the extracellular medium and promoting a specific antitumor 
immune response (20, 21). However, when we looked at poten-
tial DAMPs in 213Bi-treated MM cell supernatants, we could 
not detect any significant release of HMGB1, Hsp70, or TNFα 
or membrane expression of Hsp70, Hsp90, or calreticulin on 
irradiated tumor cells. Interestingly, no DC activation was seen 
when irradiated culture media were subjected to freeze-thaw 
cycle. This loss of biological activity suggests that the activation 
factor is unstable but does not provide insights on its molecular 
nature. Therefore, it would be important to screen other proin-
flammatory cytokines. Alternatively, based on current literature, 
it would be interesting to dose ATP or ROS.
In summary, this radiobiology study shows that 213Bi 
induces DSBs in MM cells, followed by cell proliferation arrest 
related to cell cycle blockade in G2 phase, finally leading to cell 
death. We only observed low levels of apoptosis, and necrosis 
seems to be the major cell death mode induced in MM cells 
after treatment with 213Bi. In addition, 213Bi irradiation induces 
autophagy in MM cells, which could be involved in initial 
proliferation arrest and cell death. Finally, this study opens new 
prospects on α-particle action since induction of autophagy in 
MM tumor cells could be an advantageous feature to activate 
immune cells.
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